Skip to main content
NEUROPHET Inc. logo

NEUROPHET Inc. — Investor Relations & Filings

Ticker · 380550 ISIN · KR7380550004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 41 across all filing types
Latest filing 2026-03-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 380550

About NEUROPHET Inc.

http://www.neurophet.com/en

NEUROPHET Inc. is a medical artificial intelligence company that develops solutions for brain disorders. The company specializes in AI-driven brain imaging analysis software designed to support the entire lifecycle of brain disease management, from diagnosis and treatment planning to drug efficacy monitoring and clinical research. Its core technologies are applied across various neurological fields, including neurodegenerative diseases like Alzheimer's, neurovascular conditions, and neuromodulation therapies. By leveraging advanced neuroscience and AI, Neurophet aims to provide accurate and consistent analytical results to medical professionals and researchers to aid in the treatment of brain diseases.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding of Stocks, etc. (Simplified)'. This is a standard regulatory filing in South Korea (often referred to as a 5% report or major shareholding notification) required under the Capital Markets Act when an entity's shareholding in a listed company changes significantly. It details the reporting entity (Samsung Active Asset Management), the target company (Neurofit), and the specific changes in shareholding percentages and transaction history. This fits the definition of a Major Shareholding Notification (MRQ).
2026-03-03 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming 'Corporate Day' investor meeting (IR event). It provides the date, location, target audience, and purpose of the meeting, and mentions where the IR materials will be posted. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2026-03-03 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a formal announcement regarding an upcoming 'Corporate Presentation' (IR) event, specifically a Non-Deal Roadshow for institutional investors. It provides details such as the date, location, purpose, and contact information. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2026-02-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by Samsung Active Asset Management in the company 'Neurofit'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2026-01-29 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채). It details the number of shares to be issued, the conversion price, and the impact on the total number of shares. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance, which is best classified as 'Share Issue/Capital Change' (SHA).
2026-01-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Annual General Meeting). It is under 5,000 characters and serves as a formal notice of a corporate action rather than a full report or proxy statement. Since it does not fit into specific categories like dividend announcements or share issues, and acts as a general regulatory notification, it is classified as a Regulatory Filing (RNS).
2025-12-17 Korean

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.